RICE HALL JAMES & ASSOCIATES, LLC
CIK: 0001230765Latest portfolio: $1.8B · Q4 2025
Holdings
243
Total Value
$1.8B
New Positions
243
Closed Positions
0
Top Holdings
View All 243 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | LGNDLIGAND PHARMACEUTICALS INC | 279,627 | $52.9M | 2.91% | NEW | |
| 2 | ARLOARLO TECHNOLOGIES INC | 3,576,612 | $50.0M | 2.75% | NEW | |
| 3 | AM6AMICUS THERAPEUTICS INC | 3,509,571 | $50.0M | 2.75% | NEW | |
| 4 | FNFABRINET | 106,516 | $48.5M | 2.67% | NEW | |
| 5 | ESTAESTABLISHMENT LABS HLDGS INC | 651,559 | $47.5M | 2.61% | NEW | |
| 6 | TSAACI WORLDWIDE INC | 981,314 | $46.9M | 2.58% | NEW | |
| 7 | FOURSHIFT4 PMTS INC | 663,788 | $41.8M | 2.30% | NEW | |
| 8 | DFINDONNELLEY FINL SOLUTIONS INC | 765,939 | $35.8M | 1.97% | NEW | |
| 9 | MEDPMEDPACE HLDGS INC | 62,514 | $35.1M | 1.93% | NEW | |
| 10 | AWIARMSTRONG WORLD INDS INC NEW | 172,974 | $33.1M | 1.82% | NEW | |
| 11 | YOUCLEAR SECURE INC | 914,235 | $32.1M | 1.77% | NEW | |
| 12 | ASNDASCENDIS PHARMA A/S | 145,046 | $30.9M | 1.70% | NEW | |
| 13 | PBVPRESTIGE CONSMR HEALTHCARE I | 500,600 | $30.9M | 1.70% | NEW | |
| 14 | XPOXPO INC | 219,176 | $29.8M | 1.64% | NEW | |
| 15 | LRNSTRIDE INC | 427,783 | $27.8M | 1.53% | NEW | |
| 16 | VRDNVIRIDIAN THERAPEUTICS INC | 884,532 | $27.5M | 1.52% | NEW | |
| 17 | SRADSPORTRADAR GROUP AG | 1,140,417 | $27.1M | 1.49% | NEW | |
| 18 | GTLSCHART INDS INC | 128,574 | $26.5M | 1.46% | NEW | |
| 19 | JXC1ZIFF DAVIS INC | 744,232 | $26.2M | 1.44% | NEW | |
| 20 | WIXWIX COM LTD | 250,084 | $26.0M | 1.43% | NEW | |
| 21 | WEXWEX INC | 174,138 | $25.9M | 1.43% | NEW | |
| 22 | KNSAKINIKSA PHARMACEUTICALS INTL | 596,431 | $24.6M | 1.35% | NEW | |
| 23 | QDELQUIDELORTHO CORP | 833,791 | $23.8M | 1.31% | NEW | |
| 24 | SUPNSUPERNUS PHARMACEUTICALS INC | 467,886 | $23.3M | 1.28% | NEW | |
| 25 | ITRNITURAN LOCATION AND CONTROL | 528,164 | $22.7M | 1.25% | NEW |
Quarterly Changes
Sector Breakdown
Healthcare0.0% ($5.286947485351103e+261T)
Industrials0.0% ($5.0036330552978826e+179T)
Technology0.0% ($4.849441798320712e+168T)
Consumer Cyclical0.0% ($1.9082177611464513e+79T)
Unknown0.0% ($4.997646916308823e+68T)
Financial Services0.0% ($3.576119738117259e+41T)
Consumer Defensive0.0% ($2.777559182860266e+24T)
Basic Materials0.0% ($1.9972409531432181e+21T)
Communication Services0.0% ($130541287294276321280.0T)
Energy0.0% ($65524209305015910400.0T)
Filing History
| Quarter | Filing Date | Portfolio Value | Holdings |
|---|---|---|---|
| Q4 2025 | Feb 17, 2026 | $1.8B | 243 |
| Q3 2025 | Oct 16, 2025 | $1.8T | 0 |
| Q2 2025 | Aug 11, 2025 | $1.9T | 247 |
| Q1 2025 | May 1, 2025 | $1.7T | 248 |
| Q4 2024 | Jan 31, 2025 | $1820.8T | 249 |
| Q3 2024 | Oct 28, 2024 | $1847.7T | 250 |
| Q2 2024 | Aug 7, 2024 | $1667.1T | 256 |
| Q1 2024 | Apr 23, 2024 | $1751.5T | 257 |
| Q4 2023 | Feb 9, 2024 | $1726.9T | 260 |
| Q3 2023 | Nov 2, 2023 | $1574.4T | 260 |
| Q2 2023 | Jul 24, 2023 | $1762.0T | 262 |
| Q1 2023 | May 12, 2023 | $1760.3T | 262 |
| Q4 2022 | Jan 27, 2023 | $1743.6T | 260 |
| Q3 2022 | Nov 1, 2022 | $1.7T | 265 |
| Q2 2022 | Aug 8, 2022 | $2.1T | 265 |
| Q1 2022 | May 5, 2022 | $2.4T | 306 |
| Q4 2021 | Feb 14, 2022 | $2.8T | 312 |
| Q3 2021 | Nov 9, 2021 | $2.7T | 309 |
| Q2 2021 | Jul 29, 2021 | $2.8T | 313 |
| Q1 2021 | May 14, 2021 | $3.1T | 315 |
| Q4 2020 | Feb 16, 2021 | $2.8T | 300 |
| Q3 2020 | Nov 16, 2020 | $2.5T | 273 |
| Q2 2020 | Aug 14, 2020 | $2.3T | 258 |
| Q1 2020 | May 15, 2020 | $1.7T | 259 |
| Q4 2019 | Jan 29, 2020 | $3.0T | 265 |
| Q3 2019 | Oct 30, 2019 | $2.8T | 268 |
| Q2 2019 | Aug 1, 2019 | $3.0T | 273 |
| Q1 2019 | May 1, 2019 | $3.1T | 290 |
| Q4 2018 | Feb 14, 2019 | $2.7T | 293 |
| Q3 2018 | Oct 25, 2018 | $2.8T | 300 |
| Q2 2018 | Aug 2, 2018 | $2.8T | 298 |
| Q1 2018 | Apr 25, 2018 | $2.6T | 295 |
| Q4 2017 | Jan 23, 2018 | $2.5T | 299 |
| Q3 2017 | Oct 30, 2017 | $2.3T | 291 |
| Q2 2017 | Aug 2, 2017 | $2.3T | 289 |
| Q1 2017 | Apr 19, 2017 | $2.1T | 295 |
| Q4 2016 | Feb 2, 2017 | $2.0T | 296 |
| Q3 2016 | Oct 20, 2016 | $1.9T | 295 |
| Q2 2016 | Jul 27, 2016 | $1.7T | 295 |
| Q1 2016 | Apr 26, 2016 | $1.7T | 294 |
Fund Information
RICE HALL JAMES & ASSOCIATES, LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $1.8B across 243 holdings. The largest position is LIGAND PHARMACEUTICALS INC (LGND), representing 2.9% of the portfolio. Compared to the previous quarter, the fund opened 243 new positions and closed 0 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.